20 Results for "

CCL20

" in MedChemExpress (MCE) Product Catalog:
Products (20)

20 Results for "CCL20" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-151435
CAS No.: 588674-64-0
Purity:  99.30%
Target:  

CCR

Research Areas:  

Inflammation/Immunology

CCR6 antagonist 1 is a CCR6 antagonist that inhibits the CCL20/CCR6 axis. CCR6 antagonist 1 can be used in the research of autoimmune-mediated inflammatory diseases, such as inflammatory bowel diseases (IBDs) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P7260
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHuMIP-3α/CCL20; C-C motif chemokine 20; MIP3A; SCYA20
Species:  
Source:  
CHO
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P7263
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rMuMIP-3α/CCL20; C-C motif chemokine 20; MIP3A; SCYA20
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19548A
CAS No.: 222638-67-7
Target:  

Arginase

Research Areas:  

Metabolic Disease

BEC hydrochloride is a slow-binding and competitive Arginase II inhibitor with Ki of 0.31 μM and 30 nM at pH 7.5 and pH 9.5, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P7262
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHuMIP-3α/CCL20; C-C motif chemokine 20; MIP3A; SCYA20
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-162495
CAS No.: 2737274-49-4
IDOR-1117-2520 is an orally active, potent, selective and reversible CCR6 antagonist. IDOR-1117-2520 antagonizes the CCL20-mediated calcium flow (IC50 = 63 nM) and inhibits β-arrestin recruitment to human CCR6 (IC50 = 30 nM) in cells expressing recombinant human CCR6. IDOR-1117-2520 is found to be a substrate of P-gp/MDR1. IDOR-1117-2520 can be used in the research of autoimmune diseases and skin inflammation .
loading...
    loading...
Cat. No.: HY-P990592
Synonyms: E-6071; HGS-1035

Target:  

CCR

Research Areas:  

Inflammation/Immunology

GSK-3050002 (E-6071) is a CHO-expressed humanized antibody that targets CCL20. GSK-3050002 (E-6071) features a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for GSK-3050002 (E-6071) can refer to Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Cat. No.: HY-RS02090
Research Areas:  

Others

CCL20 Human Pre-designed siRNA Set A contains three designed siRNAs for CCL20 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-174762
Target:  

mRNA

Research Areas:  

Inflammation/Immunology

Human CCL20 mRNA encodes the human C-C motif chemokine ligand 20 (CCL20) protein that displays chemotactic activity for lymphocytes and can repress proliferation of myeloid progenitors.
loading...
    loading...
Cat. No.: HY-RS16609
Research Areas:  

Others

Ccl20 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ccl20 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS23043
Research Areas:  

Others

Ccl20 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ccl20 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-178053
CAS No.: 1191937-43-5
AHR agonist 10 is a potent AHR agonist (EC50 = 2.01 nM). AHR agonist 10 can elevate the transcript levels of key AHR downstream pathway target genes, including CYP1A1 and CYP1B1. AHR agonist 10 can downregulate the expression levels of CD36, IL-18 and shows low cytotoxicity (>40 μM) to normal cells. AHR agonist 10 can suppress the expression of CCL5, CCL20, IL-6, IL-8, S100A9, TLR4, TNF-α, and TNFR1, demonstrating that AHR agonist 10 effectively modulate inflammatory responses through AHR dependent signaling pathways. AHR agonist 10 can be used for psoriasis research .
loading...
    loading...
Cat. No.: HY-172161
Target:  

CCR

Research Areas:  

Inflammation/Immunology

CCR6 antagonist 2 (Compound 20c) is the antagonist for CCR6 with a Ki of 1.1 nM. CCR6 antagonist 2 inhibits CCL20-induced calcium ion influx (IC50 = 4.9 nM), inhibits the chemotactic migration of CCR6+ T cells (IC50 = 190 nM) .
loading...
    loading...
Cat. No.: HY-162495A
(S)-IDOR-1117-2520 is the S-isomer of IDOR-1117-2520 (HY-162495). IDOR-1117-2520 is an orally active, potent, selective and reversible CCR6 antagonist. IDOR-1117-2520 antagonizes the CCL20-mediated calcium flow (IC50 = 63 nM) and inhibits β-arrestin recruitment to human CCR6 (IC50 = 30 nM) in cells expressing recombinant human CCR6. IDOR-1117-2520 is found to be a substrate of P-gp/MDR1. IDOR-1117-2520 can be used in the research of autoimmune diseases and skin inflammation .
loading...
    loading...
Cat. No.: HY-P7261
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rRtMIP-3α/CCL20; C-C motif chemokine 20; MIP3A; SCYA20
Species:  
Rat
Source:  
loading...
    loading...
Cat. No.: HY-P73814
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: C-C motif chemokine 20; MIP3A; SCYA20
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P73813
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: C-C motif chemokine 20; MIP3A; SCYA20
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P700549
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: rHuMIP-3α/CCL20; C-C motif chemokine 20; MIP3A; SCYA20
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P700550
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: rHuMIP-3α/CCL20; C-C motif chemokine 20; MIP3A; SCYA20
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P700551
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: rHuMIP-3α/CCL20; C-C motif chemokine 20; MIP3A; SCYA20
Species:  
Source:  
loading...
    loading...
  • 1